Instances of MTC in people treated with liraglutide, A different GLP-one receptor agonist, have already been described during the postmarketing interval; the data in these reports are insufficient to determine or exclude a causal romantic relationship concerning MTC and GLP-1 receptor agonist use in people. There have been some stories of thyroi